Global Eye Drops for Glaucoma Market Growth 2025-2031

Publication ID:

LPI04252140

Publication Date:

April 25, 2025

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Eye Drops for Glaucoma market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Eye Drops for Glaucoma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Eye Drops for Glaucoma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Eye Drops for Glaucoma is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Eye Drops for Glaucoma players cover Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, Zentiva, Upjohn UK Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淓ye Drops for Glaucoma Industry Forecast鈥� looks at past sales and reviews total world Eye Drops for Glaucoma sales in 2024, providing a comprehensive analysis by region and market sector of projected Eye Drops for Glaucoma sales for 2025 through 2031. With Eye Drops for Glaucoma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Eye Drops for Glaucoma industry.
This Insight Report provides a comprehensive analysis of the global Eye Drops for Glaucoma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Eye Drops for Glaucoma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Eye Drops for Glaucoma market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Eye Drops for Glaucoma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Eye Drops for Glaucoma.
This report presents a comprehensive overview, market shares, and growth opportunities of Eye Drops for Glaucoma market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Bimatoprost
Latanoprost
Tafluprost
Travoprost
Segmentation by Application:
Hospital
Ophthalmic Clinic
Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thea Pharmaceuticals Ltd
FDC International Ltd
Martindale Pharma
Zentiva
Upjohn UK Limited
Beacon Pharmaceuticals
Novartis Pharmaceuticals UK Ltd
Mylan
Accord Healthcare Limited
Sandoz Limited
Thornton & Ross Ltd
Aspire Pharma Ltd
AbbVie Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Eye Drops for Glaucoma market?
What factors are driving Eye Drops for Glaucoma market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Eye Drops for Glaucoma market opportunities vary by end market size?
How does Eye Drops for Glaucoma break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eye Drops for Glaucoma Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Eye Drops for Glaucoma by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Eye Drops for Glaucoma by Country/Region, 2020, 2024 & 2031
2.2 Eye Drops for Glaucoma Segment by Type
2.2.1 Bimatoprost
2.2.2 Latanoprost
2.2.3 Tafluprost
2.2.4 Travoprost
2.3 Eye Drops for Glaucoma Sales by Type
2.3.1 Global Eye Drops for Glaucoma Sales Market Share by Type (2020-2025)
2.3.2 Global Eye Drops for Glaucoma Revenue and Market Share by Type (2020-2025)
2.3.3 Global Eye Drops for Glaucoma Sale Price by Type (2020-2025)
2.4 Eye Drops for Glaucoma Segment by Application
2.4.1 Hospital
2.4.2 Ophthalmic Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Eye Drops for Glaucoma Sales by Application
2.5.1 Global Eye Drops for Glaucoma Sale Market Share by Application (2020-2025)
2.5.2 Global Eye Drops for Glaucoma Revenue and Market Share by Application (2020-2025)
2.5.3 Global Eye Drops for Glaucoma Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Eye Drops for Glaucoma Breakdown Data by Company
3.1.1 Global Eye Drops for Glaucoma Annual Sales by Company (2020-2025)
3.1.2 Global Eye Drops for Glaucoma Sales Market Share by Company (2020-2025)
3.2 Global Eye Drops for Glaucoma Annual Revenue by Company (2020-2025)
3.2.1 Global Eye Drops for Glaucoma Revenue by Company (2020-2025)
3.2.2 Global Eye Drops for Glaucoma Revenue Market Share by Company (2020-2025)
3.3 Global Eye Drops for Glaucoma Sale Price by Company
3.4 Key Manufacturers Eye Drops for Glaucoma Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eye Drops for Glaucoma Product Location Distribution
3.4.2 Players Eye Drops for Glaucoma Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Eye Drops for Glaucoma by Geographic Region
4.1 World Historic Eye Drops for Glaucoma Market Size by Geographic Region (2020-2025)
4.1.1 Global Eye Drops for Glaucoma Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Eye Drops for Glaucoma Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Eye Drops for Glaucoma Market Size by Country/Region (2020-2025)
4.2.1 Global Eye Drops for Glaucoma Annual Sales by Country/Region (2020-2025)
4.2.2 Global Eye Drops for Glaucoma Annual Revenue by Country/Region (2020-2025)
4.3 Americas Eye Drops for Glaucoma Sales Growth
4.4 APAC Eye Drops for Glaucoma Sales Growth
4.5 Europe Eye Drops for Glaucoma Sales Growth
4.6 Middle East & Africa Eye Drops for Glaucoma Sales Growth
5 Americas
5.1 Americas Eye Drops for Glaucoma Sales by Country
5.1.1 Americas Eye Drops for Glaucoma Sales by Country (2020-2025)
5.1.2 Americas Eye Drops for Glaucoma Revenue by Country (2020-2025)
5.2 Americas Eye Drops for Glaucoma Sales by Type (2020-2025)
5.3 Americas Eye Drops for Glaucoma Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eye Drops for Glaucoma Sales by Region
6.1.1 APAC Eye Drops for Glaucoma Sales by Region (2020-2025)
6.1.2 APAC Eye Drops for Glaucoma Revenue by Region (2020-2025)
6.2 APAC Eye Drops for Glaucoma Sales by Type (2020-2025)
6.3 APAC Eye Drops for Glaucoma Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eye Drops for Glaucoma by Country
7.1.1 Europe Eye Drops for Glaucoma Sales by Country (2020-2025)
7.1.2 Europe Eye Drops for Glaucoma Revenue by Country (2020-2025)
7.2 Europe Eye Drops for Glaucoma Sales by Type (2020-2025)
7.3 Europe Eye Drops for Glaucoma Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eye Drops for Glaucoma by Country
8.1.1 Middle East & Africa Eye Drops for Glaucoma Sales by Country (2020-2025)
8.1.2 Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2020-2025)
8.2 Middle East & Africa Eye Drops for Glaucoma Sales by Type (2020-2025)
8.3 Middle East & Africa Eye Drops for Glaucoma Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eye Drops for Glaucoma
10.3 Manufacturing Process Analysis of Eye Drops for Glaucoma
10.4 Industry Chain Structure of Eye Drops for Glaucoma
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eye Drops for Glaucoma Distributors
11.3 Eye Drops for Glaucoma Customer
12 World Forecast Review for Eye Drops for Glaucoma by Geographic Region
12.1 Global Eye Drops for Glaucoma Market Size Forecast by Region
12.1.1 Global Eye Drops for Glaucoma Forecast by Region (2026-2031)
12.1.2 Global Eye Drops for Glaucoma Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Eye Drops for Glaucoma Forecast by Type (2026-2031)
12.7 Global Eye Drops for Glaucoma Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Thea Pharmaceuticals Ltd
13.1.1 Thea Pharmaceuticals Ltd Company Information
13.1.2 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product Portfolios and Specifications
13.1.3 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thea Pharmaceuticals Ltd Main Business Overview
13.1.5 Thea Pharmaceuticals Ltd Latest Developments
13.2 FDC International Ltd
13.2.1 FDC International Ltd Company Information
13.2.2 FDC International Ltd Eye Drops for Glaucoma Product Portfolios and Specifications
13.2.3 FDC International Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 FDC International Ltd Main Business Overview
13.2.5 FDC International Ltd Latest Developments
13.3 Martindale Pharma
13.3.1 Martindale Pharma Company Information
13.3.2 Martindale Pharma Eye Drops for Glaucoma Product Portfolios and Specifications
13.3.3 Martindale Pharma Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Martindale Pharma Main Business Overview
13.3.5 Martindale Pharma Latest Developments
13.4 Zentiva
13.4.1 Zentiva Company Information
13.4.2 Zentiva Eye Drops for Glaucoma Product Portfolios and Specifications
13.4.3 Zentiva Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Zentiva Main Business Overview
13.4.5 Zentiva Latest Developments
13.5 Upjohn UK Limited
13.5.1 Upjohn UK Limited Company Information
13.5.2 Upjohn UK Limited Eye Drops for Glaucoma Product Portfolios and Specifications
13.5.3 Upjohn UK Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Upjohn UK Limited Main Business Overview
13.5.5 Upjohn UK Limited Latest Developments
13.6 Beacon Pharmaceuticals
13.6.1 Beacon Pharmaceuticals Company Information
13.6.2 Beacon Pharmaceuticals Eye Drops for Glaucoma Product Portfolios and Specifications
13.6.3 Beacon Pharmaceuticals Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Beacon Pharmaceuticals Main Business Overview
13.6.5 Beacon Pharmaceuticals Latest Developments
13.7 Novartis Pharmaceuticals UK Ltd
13.7.1 Novartis Pharmaceuticals UK Ltd Company Information
13.7.2 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product Portfolios and Specifications
13.7.3 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Novartis Pharmaceuticals UK Ltd Main Business Overview
13.7.5 Novartis Pharmaceuticals UK Ltd Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Eye Drops for Glaucoma Product Portfolios and Specifications
13.8.3 Mylan Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Accord Healthcare Limited
13.9.1 Accord Healthcare Limited Company Information
13.9.2 Accord Healthcare Limited Eye Drops for Glaucoma Product Portfolios and Specifications
13.9.3 Accord Healthcare Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Accord Healthcare Limited Main Business Overview
13.9.5 Accord Healthcare Limited Latest Developments
13.10 Sandoz Limited
13.10.1 Sandoz Limited Company Information
13.10.2 Sandoz Limited Eye Drops for Glaucoma Product Portfolios and Specifications
13.10.3 Sandoz Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sandoz Limited Main Business Overview
13.10.5 Sandoz Limited Latest Developments
13.11 Thornton & Ross Ltd
13.11.1 Thornton & Ross Ltd Company Information
13.11.2 Thornton & Ross Ltd Eye Drops for Glaucoma Product Portfolios and Specifications
13.11.3 Thornton & Ross Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Thornton & Ross Ltd Main Business Overview
13.11.5 Thornton & Ross Ltd Latest Developments
13.12 Aspire Pharma Ltd
13.12.1 Aspire Pharma Ltd Company Information
13.12.2 Aspire Pharma Ltd Eye Drops for Glaucoma Product Portfolios and Specifications
13.12.3 Aspire Pharma Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Aspire Pharma Ltd Main Business Overview
13.12.5 Aspire Pharma Ltd Latest Developments
13.13 AbbVie Ltd
13.13.1 AbbVie Ltd Company Information
13.13.2 AbbVie Ltd Eye Drops for Glaucoma Product Portfolios and Specifications
13.13.3 AbbVie Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 AbbVie Ltd Main Business Overview
13.13.5 AbbVie Ltd Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂